R.L. Siegel, K.D. Miller, H.E. Fuchs, A. Jemal, Cancer Statistics, 2021. CA Cancer J Clin. 71(1), 7–33 (2021)

K.D. Miller, L. Nogueira, A.B. Mariotto, J.H. Rowland, K.R. Yabroff, C.M. Alfano et al., Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 69(5), 363–385 (2019)

Article  PubMed  Google Scholar 

W.-L. Tan, A. Jain, A. Takano, E.W. Newell, N.G. Iyer, W.-T. Lim et al., Novel therapeutic targets on the horizon for Lung cancer. Lancet Oncol. 17(8), e347–e62 (2016)

Article  CAS  PubMed  Google Scholar 

X. Hu, J. Li, M. Fu, X. Zhao, W. Wang, The JAK/STAT signaling pathway: from bench to clinic. Signal. Transduct. Target. Ther. 6(1), 402 (2021)

Article  PubMed  PubMed Central  Google Scholar 

K. Inagaki-Ohara, T. Kondo, M. Ito, A. Yoshimura, SOCS, inflammation, and cancer. JAKSTAT. 2(3), e24053 (2013)

PubMed  PubMed Central  Google Scholar 

J.J. Babon, N.A. Nicola, The biology and mechanism of action of suppressor of cytokine signaling 3. Growth Factors. 30(4), 207–219 (2012)

Article  CAS  PubMed  PubMed Central  Google Scholar 

L. Dai, Z. Li, Y. Tao, W. Liang, W. Hu, S. Zhou et al., Emerging roles of suppressor of cytokine signaling 3 in human cancers. Biomed. Pharmacother. 144, 112262 (2021)

Article  CAS  PubMed  Google Scholar 

Y. Ben-Neriah, M. Karin, Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat. Immunol. 12(8), 715–723 (2011)

Article  CAS  PubMed  Google Scholar 

R. Caruso, N. Warner, N. Inohara, G. Nunez, NOD1 and NOD2: signaling, host defense, and inflammatory Disease. Immunity. 41(6), 898–908 (2014)

Article  CAS  PubMed  PubMed Central  Google Scholar 

M.L. Disis, Immune regulation of cancer. J. Clin. Oncol. 28(29), 4531–4538 (2010)

Article  CAS  PubMed  PubMed Central  Google Scholar 

M.J. Smyth, G.P. Dunn, R.D. Schreiber, Cancer Immunosurveillance and Immunoediting: The Roles of Immunity in Suppressing Tumor Development and Shaping Tumor Immunogenicity. Adv. Immunol. 90, 1–50 (2006)

M.A. Huber, N. Azoitei, B. Baumann, S. Grünert, A. Sommer, H. Pehamberger et al., NF-κB is essential for epithelial-mesenchymal transition and Metastasis in a model of Breast cancer progression. J. Clin. Invest. 114(4), 569–581 (2004)

Article  CAS  PubMed  PubMed Central  Google Scholar 

H.J. Maier, U. Schmidt-Strassburger, M.A. Huber, E.M. Wiedemann, H. Beug, T. Wirth, NF-kappaB promotes epithelial-mesenchymal transition, migration and invasion of pancreatic carcinoma cells. Cancer Lett. 295(2), 214–228 (2010)

Article  CAS  PubMed  Google Scholar 

S.J. Kim, T. Hyeong Lee, S. Hee Nam, J.H. Kim, S. Oh, Y. Sook Cho et al., Association of Uba6-Specific-E2 (USE1) with Lung Tumorigenesis. J. Natl. Cancer Inst. 109(3), 1–11 (2017)

Article  PubMed  Google Scholar 

J.O. Jin, G.D. Lee, S.H. Nam, T.H. Lee, D.H. Kang, J.K. Yun et al., Sequential ubiquitination of p53 by TRIM28, RLIM, and MDM2 in lung tumorigenesis. Cell. Death Differ. 28(6), 1790–1803 (2021)

Article  CAS  PubMed  Google Scholar 

K.H. Lee, A. Biswas, Y.J. Liu, K.S. Kobayashi, Proteasomal degradation of Nod2 protein mediates tolerance to bacterial cell wall components. J. Biol. Chem. 287(47), 39800–39811 (2012)

Article  CAS  PubMed  PubMed Central  Google Scholar 

X. Ma, Y. Qiu, Y. Sun, L. Zhu, Y. Zhao, T. Li et al., NOD2 inhibits tumorigenesis and increases chemosensitivity of hepatocellular carcinoma by targeting AMPK pathway. Cell. Death Dis. 11(3), 174 (2020)

Article  CAS  PubMed  PubMed Central  Google Scholar 

S.M.N. Udden, L. Peng, J.L. Gan, J.M. Shelton, J.S. Malter, L.V. Hooper et al., NOD2 suppresses colorectal tumorigenesis via downregulation of the TLR pathways. Cell. Rep. 19(13), 2756–2770 (2017)

Article  CAS  PubMed  PubMed Central  Google Scholar 

T. Kawai, S. Akira, The roles of TLRs, RLRs and NLRs in pathogen recognition. Int. Immunol. 21(4), 317–337 (2009)

Article  CAS  PubMed  PubMed Central  Google Scholar 

F.R. Hirsch, G.V. Scagliotti, J.L. Mulshine, R. Kwon, W.J. Curran, Y.-L. Wu et al., Lung cancer: current therapies and new targeted treatments. The Lancet. 389(10066), 299–311 (2017)

Article  CAS  Google Scholar 

Y. Yin, W. Liu, Y. Dai, SOCS3 and its role in associated Diseases. Hum. Immunol. 76(10), 775–780 (2015)

Article  CAS  PubMed  Google Scholar 

L.H. Jiang, Y.L. Hao, J.W. Zhu, Expression and prognostic value of HER-2/neu, STAT3 and SOCS3 in hepatocellular carcinoma. Clin. Res. Hepatol. Gastroenterol. 43(3), 282–291 (2019)

Article  CAS  PubMed  Google Scholar 

K. Inagaki-Ohara, H. Mayuzumi, S. Kato, Y. Minokoshi, T. Otsubo, Y.I. Kawamura et al., Enhancement of leptin receptor signaling by SOCS3 deficiency induces development of gastric tumors in mice. Oncogene. 33(1), 74–84 (2014)

Article  CAS  PubMed  Google Scholar 

M. Ying, D. Li, L. Yang, M. Wang, N. Wang, Y. Chen et al., Loss of SOCS3 expression is associated with an increased risk of recurrent Disease in breast carcinoma. J. Cancer Res. Clin. Oncol. 136(10), 1617–1626 (2010)

Article  CAS  PubMed  Google Scholar 

Y. Dong, S. Wang, C. Wang, Z. Li, Y. Ma, G. Liu, Antagonizing NOD2 Signaling with conjugates of Paclitaxel and Muramyl dipeptide derivatives sensitizes Paclitaxel Therapy and significantly prevents Tumor Metastasis. J. Med. Chem. 60(3), 1219–1224 (2017)

Article  CAS  PubMed  Google Scholar 

D.P. Chen, W.R. Ning, X.F. Li, Y. Wei, X.M. Lao, J.C. Wang et al., Peritumoral monocytes induce cancer cell autophagy to facilitate the progression of human hepatocellular carcinoma. Autophagy. 14(8), 1335–1346 (2018)

Article  CAS  PubMed  PubMed Central  Google Scholar 

T. Yamaoka, S. Arata, M. Homma, T. Homma, S. Kusumoto, K. Ando et al., Blockade of EGFR activation promotes TNF-Induced Lung epithelial cell apoptosis and Pulmonary Injury. Int. J. Mol. Sci. 20(16), 4021 (2019)